MENU
IMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immuron (IMRN) Ownership - Who owns Immuron?

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
25-37, Chapman Street
Phone
+61 388924854
Employees
8
Web
https://www.immuron.com.au

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.71M
P/E Ratio
-1.68
Total Cash
9.02M
Projected Growth
N/A
Total Debt
192.79K
Revenue
7.71M
Risk (Beta)
1.72
Dividend Yield
N/A
Total Cash/Share
1.12
Total Debt/Equity
N/A
Revenue/Share
0.73 USD as % of share price
Who owns Immuron? IMRN symbol Ownership - Tickeron.com